PSMD10/gankyrin induces autophagy to promote tumor progression through cytoplasmic interaction with ATG7 and nuclear transactivation of ATG7 expression

Autophagy

Volumn 12, Issue 8, 2016, Pages 1355-1371

  Luo, Tao ^a,b   Fu, Jing ^a,b   Xu, An ^a,b   Su, Bo ^a   Ren, Yibing ^a,b   Li, Ning ^a   Zhu, Junjie ^a   Zhao, Xiaofang ^a   Dai, Rongyang ^a   Cao, Jie ^a   Wang, Bibo ^a   Qin, Wenhao ^a   Jiang, Jinhua ^a   Li, Juan ^d   Wu, Mengchao ^a   Feng, Gensheng ^a   Chen, Yao ^a,b   Wang, Hongyang ^a,b,c  

^a Eastern Hepatobiliary Surgery Institute/Hospital   (China)

^b National Center for Liver Cancer   (China)

^c SHANGHAI JIAO TONG UNIVERSITY SCHOOL OF MEDICINE   (China)

^d SECOND MILITARY MEDICAL UNIVERSITY   (China)

Author keywords

ATG7; autophagy; drug resistance; hepatocellular carcinoma; HSF1; PSMD10; sorafenib

Indexed keywords

ANTINEOPLASTIC AGENT; AUTOPHAGY PROTEIN 7; BECLIN 1; HEAT SHOCK TRANSCRIPTION FACTOR 1; ONCOPROTEIN; PROTEASOME; PROTEIN; PROTEIN P53; PSMD10 PROTEIN; SORAFENIB; UNCLASSIFIED DRUG; ATG7 PROTEIN, HUMAN; ATP DEPENDENT 26S PROTEASE; AUTOPHAGY RELATED PROTEIN 7; HEAT SHOCK TRANSCRIPTION FACTOR; HSF1 PROTEIN, HUMAN; PROTEIN BINDING; PSMD10 PROTEIN, HUMAN;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; AUTOLYSOSOME; AUTOPHAGOSOME; AUTOPHAGY; CANCER PROGNOSIS; CANCER RESISTANCE; CELLULAR DISTRIBUTION; CYTOPLASM; HUMAN; HUMAN CELL; LIVER CELL CARCINOMA; MOUSE; NONHUMAN; PROTEIN EXPRESSION; PROTEIN LOCALIZATION; TUMOR GROWTH; UPREGULATION; ANIMAL; CANCER TRANSPLANTATION; CELL NUCLEUS; CELL PROLIFERATION; CELL SURVIVAL; DISEASE EXACERBATION; LIVER TUMOR; MALE; METABOLISM; NUCLEOCYTOPLASMIC TRANSPORT; NUDE MOUSE; PROGNOSIS; TRANSCRIPTION INITIATION; TRANSGENIC MOUSE; TUMOR CELL LINE;

ACTIVE TRANSPORT, CELL NUCLEUS; ANIMALS; AUTOPHAGY; AUTOPHAGY-RELATED PROTEIN 7; CARCINOMA, HEPATOCELLULAR; CELL LINE, TUMOR; CELL NUCLEUS; CELL PROLIFERATION; CELL SURVIVAL; CYTOPLASM; DISEASE PROGRESSION; HEAT SHOCK TRANSCRIPTION FACTORS; HUMANS; LIVER NEOPLASMS; MALE; MICE; MICE, NUDE; MICE, TRANSGENIC; NEOPLASM TRANSPLANTATION; PROGNOSIS; PROTEASOME ENDOPEPTIDASE COMPLEX; PROTEIN BINDING; PROTO-ONCOGENE PROTEINS; TRANSCRIPTIONAL ACTIVATION;

EID: 84976598271     PISSN: 15548627     EISSN: 15548635     Source Type: Journal    
DOI: 10.1080/15548627.2015.1034405     Document Type: Article

References (49)

1. Y.Kondo, T.Kanzawa, R.Sawaya, S.Kondo. The role of autophagy in cancer development and response to therapy. Nat Rev Cancer 2005; 5:726–34; PMID:16148885; http://dx.doi.org/10.1038/nrc1692
2. A.M.Choi, S.W.Ryter, B.Levine. Autophagy in human health and disease. N Engl J Med 2013; 368:1845–6; PMID:23656658; http://dx.doi.org/10.1056/NEJMra1205406
3. R.Mathew, V.Karantza-Wadsworth, E.White. Role of autophagy in cancer. Nat Rev Cancer 2007; 7:961–7; PMID:17972889; http://dx.doi.org/10.1038/nrc2254
4. A.Takamura, M.Komatsu, T.Hara, A.Sakamoto, C.Kishi, S.Waguri, Y.Eishi, O.Hino, K.Tanaka, N.Mizushima. Autophagy-deficient mice develop multiple liver tumors. Genes Dev 2011; 25:795–800; PMID:21498569; http://dx.doi.org/10.1101/gad.2016211
5. X.Qu, J.Yu, G.Bhagat, N.Furuya, H.Hibshoosh, A.Troxel, J.Rosen, E.L.Eskelinen, N.Mizushima, Y.Ohsumi, et al. Promotion of tumorigenesis by heterozygous disruption of the beclin 1 autophagy gene. J Clin Invest 2003; 112:1809–20; PMID:14638851; http://dx.doi.org/10.1172/JCI20039
6. S.Yang, X.Wang, G.Contino, M.Liesa, E.Sahin, H.Ying, A.Bause, Y.Li, J.M.Stommel, G.Dell'antonio, et al. Pancreatic cancers require autophagy for tumor growth. Genes Dev 2011; 25:717–29; PMID:21406549; http://dx.doi.org/10.1101/gad.2016111
7. K.Degenhardt, R.Mathew, B.Beaudoin, K.Bray, D.Anderson, G.Chen, C.Mukherjee, Y.Shi, C.Gélinas, Y.Fan, et al. Autophagy promotes tumor cell survival and restricts necrosis, inflammation, and tumorigenesis. Cancer Cell 2006; 10:51–64; PMID:16843265; http://dx.doi.org/10.1016/j.ccr.2006.06.001
8. J.Song, Z.Qu, X.Guo, Q.Zhao, X.Zhao, L.Gao, K.Sun, F.Shen, M.Wu, L.Wei. Hypoxia-induced autophagy contributes to the chemoresistance of hepatocellular carcinoma cells. Autophagy 2009; 5:1131–44; PMID:19786832; http://dx.doi.org/10.4161/auto.5.8.9996
9. Y.H.Shi, Z.B.Ding, J.Zhou, B.Hui, G.M.Shi, A.W.Ke, X.Y.Wang, Z.Dai, Y.F.Peng, C.Y.Gu, et al. Targeting autophagy enhances sorafenib lethality for hepatocellular carcinoma via ER stress-related apoptosis. Autophagy 2011; 7:1159–72; PMID:21691147; http://dx.doi.org/10.4161/auto.7.10.16818
10. W.L.Sun, J.Chen, Y.P.Wang, H.Zheng. Autophagy protects breast cancer cells from epirubicin-induced apoptosis and facilitates epirubicin-resistance development. Autophagy 2011; 7:1035–44; PMID:21646864; http://dx.doi.org/10.4161/auto.7.9.16521
11. H.Higashitsuji, K.Itoh, T.Nagao, S.Dawson, K.Nonoguchi, T.Kido, R.J.Mayer, S.Arii, J.Fujita. Reduced stability of retinoblastoma protein by gankyrin, an oncogenic ankyrin-repeat protein overexpressed in he patomas. Nat Med 2000; 6:96–9; PMID:10613832; http://dx.doi.org/10.1038/71600
12. H.Higashitsuji, K.Itoh, T.Sakurai, T.Nagao, Y.Sumitomo, T.Masuda, S.Dawson, Y.Shimada, R.J.Mayer, J.Fujita. The oncoprotein gankyrin binds to MDM2/HDM2, enhancing ubiquitylation and degradation of p53. Cancer Cell 2005; 8:75–87; PMID:16023600; http://dx.doi.org/10.1016/j.ccr.2005.06.006
13. J.Fu, Y.Chen, J.Cao, T.Luo, Y.W.Qian, W.Yang, Y.B.Ren, B.Su, G.W.Cao, Y.Yang, et al. p28GANK overexpression accelerates hepatocellular carcinoma invasiveness and metastasis via phosphoinositol 3-kinase/AKT/hypoxia-inducible factor-1alpha pathways. Hepatology 2011; 53:181–92; PMID:21254169; http://dx.doi.org/10.1002/hep.24015
14. Y.W.Qian, Y.Chen, W.Yang, J.Fu, J.Cao, Y.B.Ren, J.J.Zhu, B.Su, T.Luo, X.F.Zhao, et al. p28(GANK) prevents degradation of Oct4 and promotes expansion of tumor-initiating cells in hepatocarcinogenesis. Gastroenterology 2012; 142:1547–58 e14; PMID:22387393; http://dx.doi.org/10.1053/j.gastro.2012.02.042
15. D.J.Klionsky, F.C.Abdalla, H.Abeliovich, R.T.Abraham, A.Acevedo-Arozena, K.Adeli, L.Agholme, M.Agnello, P.Agostinis, J.A.Aguirre-Ghiso, et al. Guidelines for the use and interpretation of assays for monitoring autophagy. Autophagy 2012; 8:445–544; PMID:22966490; http://dx.doi.org/10.4161/auto.19496
16. E.Tasdemir, M.C.Maiuri, L.Galluzzi, I.Vitale, M.Djavaheri-Mergny, M.D'Amelio, A.Criollo, E.Morselli, C.Zhu, F.Harper, et al. Regulation of autophagy by cytoplasmic p53. Nat Cell Biol 2008; 10:676–87; PMID:18454141; http://dx.doi.org/10.1038/ncb1730
17. W.Sun, J.Ding, K.Wu, B.F.Ning, W.Wen, H.Y.Sun, T.Han, L.Huang, L.W.Dong, W.Yang, et al. Gankyrin-mediated dedifferentiation facilitates the tumorigenicity of rat hepatocytes and hepatoma cells. Hepatology 2011; 54:1259–72; PMID:21735473; http://dx.doi.org/10.1002/hep.24530
18. Y.Chen, H.H.Li, J.Fu, X.F.Wang, Y.B.Ren, L.W.Dong, S.H.Tang, S.Q.Liu, M.C.Wu, H.Y.Wang. Oncoprotein p28 GANK binds to RelA and retains NF-kappaB in the cytoplasm through nuclear export. Cell Res 2007; 17:1020–9; PMID:18040287; http://dx.doi.org/10.1038/cr.2007.99
19. C.Behrends, M.E.Sowa, S.P.Gygi, J.W.Harper. Network organization of the human autophagy system. Nature 2010; 466:68–76; PMID:20562859; http://dx.doi.org/10.1038/nature09204
20. M.Komatsu, S.Waguri, T.Chiba, S.Murata, J.Iwata, I.Tanida, T.Ueno, M.Koike, Y.Uchiyama, E.Kominami, et al. Loss of autophagy in the central nervous system causes neurodegeneration in mice. Nature 20 06; 441:880–4; PMID:16625205; http://dx.doi.org/10.1038/nature04723
21. M.Komatsu, S.Waguri, T.Ueno, J.Iwata, S.Murata, I.Tanida, J.Ezaki, N.Mizushima, Y.Ohsumi, Y.Uchiyama, et al. Impairment of starvation-induced and constitutive autophagy in Atg7-deficient mice. J Cell Biol 2005; 169:425–34; PMID:15866887; http://dx.doi.org/10.1083/jcb.200412022
22. I.H.Lee, Y.Kawai, M.M.Fergusson, I.I.Rovira, A.J.Bishop, N.Motoyama, L.Cao, T.Finkel. Atg7 modulates p53 activity to regulate cell cycle and survival during metabolic stress. Science 2012; 336:225–8; PMID:22499945; http://dx.doi.org/10.1126/science.1218395
23. I.Tanida, M.Yamasaki, M.Komatsu, T.Ueno. The FAP motif within human ATG7, an autophagy-related E1-like enzyme, is essential for the E2-substrate reaction of LC3 lipidation. Autophagy 2012; 8:88–97; PMID:22170151; http://dx.doi.org/10.4161/auto.8.1.18339
24. J.S.Pattison, H.Osinska, J.Robbins. Atg7 induces basal autophagy and rescues autophagic deficiency in CryABR120G cardiomyocytes. Circ Res 2011; 109:151–60; PMID:21617129; http://dx.doi.org/10.1161/CIRCRESAHA.110.237339
25. S.Desai, Z.Liu, J.Yao, N.Patel, J.Chen, Y.Wu, E.E.Ahn, O.Fodstad, M.Tan. Heat shock factor 1 (HSF1) controls chemoresistance and autophagy through transcriptional regulation of autophagy-related protein 7 (ATG7). J Biol Chem 2013; 288:9165–76; PMID:23386620; http://dx.doi.org/10.1074/jbc.M112.422071
26. C.Dai, L.Whitesell, A.B.Rogers, S.Lindquist. Heat shock factor 1 is a powerful multifaceted modifier of carcinogenesis. Cell 2007; 130:1005–18; PMID:17889646; http://dx.doi.org/10.1016/j.cell.2007.07.020
27. X.Jin, D.Moskophidis, N.F.Mivechi. Heat shock transcription factor 1 is a key determinant of HCC development by regulating hepatic steatosis and metabolic syndrome. Cell Metab 2011; 14:91–103; PMID:21723507; http://dx.doi.org/10.1016/j.cmet.2011.03.025
28. M.L.Mendillo, S.Santagata, M.Koeva, G.W.Bell, R.Hu, R.M.Tamimi, E.Fraenkel, T.A.Ince, L.Whitesell, S.Lindquist. HSF1 drives a transcriptional program distinct from heat shock to support highly malignant human cancers. Cell 2012; 150:549–62; PMID:22863008; http://dx.doi.org/10.1016/j.cell.2012.06.031
29. T.Guettouche, F.Boellmann, W.S.Lane, R.Voellmy. Analysis of phosphorylation of human heat shock factor 1 in cells experiencing a stress. BMC Biochem 2005; 6:4; PMID:15760475; http://dx.doi.org/10.1186/1471-2091-6-4
30. V.I.Korolchuk, F.M.Menzies, D.C.Rubinsztein. Mechanisms of cross-talk between the ubiquitin-proteasome and autophagy-lysosome systems. FEBS Lett 2010; 584:1393–8; PMID:20040365; http://dx.doi.org/10.1016/j.febslet.2009.12.047
31. U.B.Pandey, Z.Nie, Y.Batlevi, B.A.McCray, G.P.Ritson, N.B.Nedelsky, S.L.Schwartz, N.A.DiProspero, M.A.Knight, O.Schuldiner, et al. HDAC6 rescues neurodegeneration and provides an essential link between autophagy and the UPS. Nature 2007; 447:859–63; PMID:17568747; http://dx.doi.org/10.1038/nature05853
32. T.Lamark, T.Johansen. Autophagy:links with the proteasome. Curr Opin Cell Biol 2010; 22:192–8; PMID:19962293; http://dx.doi.org/10.1016/j.ceb.2009.11.002
33. Y.Saeki, E.A.Toh, T.Kudo, H.Kawamura, K.Tanaka. Multiple proteasome-interacting proteins assist the assembly of the yeast 19S regulatory particle. Cell 2009; 137:900–13; PMID:19446323; http://dx.doi.org/10.1016/j.cell.2009.05.005
34. S.Wilhelm, C.Carter, M.Lynch, T.Lowinger, J.Dumas, R.A.Smith, B.Schwartz, R.Simantov, S.Kelley. Discovery and development of sorafenib:a multikinase inhibitor for treating cancer. Nat Rev Drug Discov 2006; 5:835–44; PMID:17016424; http://dx.doi.org/10.1038/nrd2130
35. S.Shimizu, T.Takehara, H.Hikita, T.Kodama, H.Tsunematsu, T.Miyagi, A.Hosui, H.Ishida, T.Tatsumi, T.Kanto, et al. Inhibition of autophagy potentiates the antitumor effect of the multikinase inhibitor sorafenib in hepatocellular carcinoma. Int J Cancer 2012; 131:548–57; PMID:21858812; http://dx.doi.org/10.1002/ijc.26374
36. A.Gauthier, M.Ho. Role of sorafenib in the treatment of advanced hepatocellular carcinoma:an update. Hepatol Res 2013; 43:147–54; PMID:23145926; http://dx.doi.org/10.1111/j.1872-034X.2012.01113.x
37. J.Y.Guo, H.Y.Chen, R.Mathew, J.Fan, A.M.Strohecker, G.Karsli-Uzunbas, J.J.Kamphorst, G.Chen, J.M.Lemons, V.Karantza, et al. Activated Ras requires autophagy to maintain oxidative metabolism and tumorigenesis. Genes Dev 2011; 25:460–70; PMID:21317241; http://dx.doi.org/10.1101/gad.2016311
38. E.Sandilands, B.Serrels, D.G.McEwan, J.P.Morton, J.P.Macagno, K.McLeod, C.Stevens, V.G.Brunton, W.Y.Langdon, M.Vidal, et al. Autophagic targeting of Src promotes cancer cell survival following reduced FAK signalling. Nat Cell Biol 2012; 14:51–60; PMID:22138575; http://dx.doi.org/10.1038/ncb2386
39. O.Mikhaylova, Y.Stratton, D.Hall, E.Kellner, B.Ehmer, A.F.Drew, C.A.Gallo, D.R.Plas, J.Biesiada, J.Meller, et al. VHL-regulated MiR-204 suppresses tumor growth through inhibition of LC3B-mediated autophagy in renal clear cell carcinoma. Cancer Cell 2012; 21:532–46; PMID:22516261; http://dx.doi.org/10.1016/j.ccr.2012.02.019
40. L.S.Hart, J.T.Cunningham, T.Datta, S.Dey, F.Tameire, S.L.Lehman, B.Qiu, H.Zhang, G.Cerniglia, M.Bi, et al. ER stress-mediated autophagy promotes Myc-dependent transformation and tumor growth. J Clin Invest 2012; 122:4621–34; PMID:23143306; http://dx.doi.org/10.1172/JCI62973
41. Z.Xie, D.J.Klionsky. Autophagosome formation:core machinery and adaptations. Nat Cell Biol 2007; 9:1102–9; PMID:17909521; http://dx.doi.org/10.1038/ncb1007-1102
42. Y.Chang, W.Yan, X.He, L.Zhang, C.Li, H.Huang, G.Nace, D.A.Geller, J.Lin, A.Tsung. miR-375 inhibits autophagy and reduces viability of hepatocellular carcinoma cells under hypoxic conditions. Gastroenterology 2012; 143:177–87 e8; PMID:22504094; http://dx.doi.org/10.1053/j.gastro.2012.04.009
43. C.Settembre, C.Di Malta, V.A.Polito, M.Garcia Arencibia, F.Vetrini, S.Erdin, S.U.Erdin, T.Huynh, D.Medina, P.Colella, et al. TFEB links autophagy to lysosomal biogenesis. Science 2011; 332:1429–33; PMID:21617040; http://dx.doi.org/10.1126/science.1204592
44. J.Fullgrabe, M.A.Lynch-Day, N.Heldring, W.Li, R.B.Struijk, Q.Ma, O.Hermanson, M.G.Rosenfeld, D.J.Klionsky, B.Joseph. The histone H4 lysine 16 acetyltransferase hMOF regulates the outcome of autophagy. Nature 2013; 500:468–71; PMID:23863932; http://dx.doi.org/10.1038/nature12313
45. Y.Jiang, P.Iakova, J.Jin, E.Sullivan, V.Sharin, I.H.Hong, S.Anakk, A.Mayor, G.Darlington, M.Finegold, et al. Farnesoid X receptor inhibits gankyrin in mouse livers and prevents development of liver cancer. Hepatology 2013; 57:1098–106; PMID:23172628; http://dx.doi.org/10.1002/hep.26146
46. G.M.Her, C.H.Cheng, J.R.Hong, G.S.Sundaram, J.L.Wu. Imbalance in liver homeostasis leading to hyperplasia by overexpressing either one of the Bcl-2-related genes, zfBLP1 and zfMcl-1a. Dev Dyn 2006; 235:515–23; PMID:16273521; http://dx.doi.org/10.1002/dvdy.20624
47. J.Zhao, J.J.Brault, A.Schild, P.Cao, M.Sandri, S.Schiaffino, S.H.Lecker, A.L.Goldberg. FoxO3 coordinately activates protein degradation by the autophagic/lysosomal and proteasomal pathways in atrophying muscle cells. Cell Metab 2007; 6:472–83; PMID:18054316; http://dx.doi.org/10.1016/j.cmet.2007.11.004
48. W.X.Ding, H.M.Ni, W.Gao, T.Yoshimori, D.B.Stolz, D.Ron, X.M.Yin. Linking of autophagy to ubiquitin-proteasome system is important for the regulation of endoplasmic reticulum stress and cell viability. Am J Pathol 2007; 171:513–24; PMID:17620365; http://dx.doi.org/10.2353/ajpath.2007.070188
49. A.C.Kimmelman. The dynamic nature of autophagy in cancer. Genes Dev 2011; 25:1999–2010; PMID:21979913; http://dx.doi.org/10.1101/gad.17558811